Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial
Authors:
Open Access
- 27 July 2022
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 54 (10) , 1335-1341
Abstract
No abstract availableKeywords
Funding Information
- Ministère des Affaires Sociales et de la Santé
- French Government Ministry of Social Affairs Health and Womens Rights (PHRC-K 2019 Inca-DGOS_14333, PRT-K 2020–15324)
- Meso Scale Diagnostics
- Institut National Du Cancer
- Merck Sharp and Dohme France
This publication has 33 references indexed in Scilit:
- Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term OutcomesJAMA Oncology, 2016
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC StudyJournal of Clinical Oncology, 2015
- PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyNew England Journal of Medicine, 2015
- Is microsatellite instability a prognostic marker in gastric cancer?: A systematic review with meta-analysisJournal of Surgical Oncology, 2014
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant ChemotherapyJournal of Thoracic Oncology, 2012
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal CancerJournal of Clinical Oncology, 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorialContemporary Clinical Trials, 2008
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2003